Skip to main content
PMC home page
Scientific Reports logoLink to Scientific Reports
. 2017 Oct 10;7:12911. doi: 10.1038/s41598-017-11756-2

Transient postnatal overfeeding causes liver stress-induced premature senescence in adult mice

Catherine Yzydorczyk 1,✉, Na Li 2, Hassib Chehade 1, Dolores Mosig 1, Mickael Bidho 1, Basile Keshavjee 1, Jean Baptiste Armengaud 1, Katya Nardou 1, Benazir Siddeek 1, Mohamed Benahmed 1, Catherine Vergely 2,#, Umberto Simeoni 1,#
PMCID: PMC5635041  PMID: 29018245

Abstract

Unbalanced nutrition early in life is increasingly recognized as an important factor in the development of chronic, non-communicable diseases at adulthood, including metabolic diseases. We aimed to determine whether transient postnatal overfeeding (OF) leads to liver stress-induced premature senescence (SIPS) of hepatocytes in association with liver structure and hepatic function alterations. Litters sizes of male C57BL/6 mice were adjusted to 9 pups (normal feeding, NF) or reduced to 3 pups during the lactation period to induce transient postnatal OF. Compared to the NF group, seven-month-old adult mice transiently overfed during the postnatal period were overweight and developed glucose intolerance and insulin resistance. Their livers showed microsteatosis and fibrosis, while hepatic insulin signaling and glucose transporter protein expressions were altered. Increased hepatic oxidative stress (OS) was observed, with increased superoxide anion production, glucose-6-phosphate dehydrogenase protein expression, oxidative DNA damage and decreased levels of antioxidant defense markers, such as superoxide dismutase and catalase proteins. Hepatocyte senescence was characterized by increased p21WAF, p53, Acp53, p16INK4a and decreased pRb/Rb and Sirtuin-1 (SIRT-1) protein expression levels. Transient postnatal OF induces liver OS at adulthood, associated with hepatocyte SIPS and alterations in liver structure and hepatic functions, which could be mediated by a SIRT-1 deficiency.

Introduction

The prevalence of overweight and obesity, which are important risk factors for cardiovascular and metabolic diseases such as type 2 diabetes, insulin resistance and non-alcoholic fatty liver disease1,2, has dramatically increased over recent decades. Particularly alarming is the large increase in childhood obesity worldwide over the past three decades3, associated with an increased occurrence of metabolic syndrome in children and adolescents as well as type-2 diabetes in young adults4. Results from epidemiological studies have shown that an altered nutritional environment during the critical developmental period early in life increases the risk of developing cardiovascular and metabolic disorders thereafter5. Notably, in humans, overnutrition during the perinatal period has been linked to obesity and the associated comorbidities. In rodents, reducing the litter size after birth decreases competition for milk during the suckling period and therefore induces over-nourishment in the postnatal period, which in turn leads to increased body weight and fat content at weaning6. Furthermore, transient postnatal overfeeding (OF) provokes metabolic (e.g., hyperphagia, overweight, insulin resistance, higher total and visceral fat mass, altered lipid profile) and cardiovascular (e.g., hypertension, cardiac dysfunction) disorders in adulthood, often associated with increased oxidative stress (OS)7–15. The liver is considered the most vulnerable organ to altered nutritional programming during the perinatal period16. The liver plays an important role in the maintenance of lipid and glucose homeostasis and is particularly susceptible to OS-induced damage17,18. The overproduction of reactive oxygen species (ROS) and nitrogen species can induce hepatocyte dysfunction, which contributes to the pathogenesis of acute and chronic liver diseases19 and to the onset or maintenance of glucose intolerance and insulin resistance20. Cell senescence, a sustained anti-proliferative response arresting the cell cycle, has also been associated with metabolic disorders21. Depending on the activating signals, senescence can be either replicative or premature. Replicative senescence is characterized by a finite replicative potential that limits the lifespan of a cell to a certain number of divisions. This process is induced via signals triggered by telomere shortening22. On the other hand, stress-induced premature senescence (SIPS) is caused in young cells via different mechanisms, such as OS23. Hepatocyte senescence has been linked to chronic liver disease24. However, to our knowledge, no studies have demonstrated the role of OS in association with adulthood hepatocyte SIPS and dysfunction secondary to early postnatal OF. Using a mouse model of transient postnatal OF induced by reducing the litter size during the lactation period, we studied the association between OS, SIPS, and liver structure and function alterations in adulthood. We also investigated whether such dysfunctions were already present earlier in life.

Results

Body weight and body composition

During the neonatal suckling period, weight gain was significantly higher in pups raised in OF mice. At postnatal day (PND) 24, the body weight of the OF litter was 63% higher than that of mice in the normal feeding (NF) litter (OF (n = 8) vs. NF (n = 8) (mean (g) ± SD): 12.65 ± 0.4 vs. 7.77 ± 0.46; p < 0.001) (Table 1). This difference persisted during growth and maturation, but to a lesser extent; at 7 months of life, the body weight in the OF group was 11.7% greater than that in the NF group (OF (n = 8) vs. NF (n = 8) (mean (g) ± SD): 34.69 ± 1.99 g vs. 31.05 ± 1.71 g; p < 0.001) (Table 1). However, a major increase in body fat mass (OF (n = 8) vs. NF (n = 8) (mean (%) ± SD): 14.9 ± 4.6 vs. 6.4 ± 1.1; p < 0.001) was observed in the OF group (Table 1).

Table 1.

Body weight (g) and fat mass percentage of NF and OF mice at PND24 and 7 months of age.

Postnatally normally fed (NF) mice; n = 8 Postnatally overfed (OF) mice; n = 8 Significance
Body weight (PND 24) 7.77 ± 0.46 12.65 ± 0.4 ***
Body weight (7 months) 31.05 ± 1.71 34.69 ± 1.99 ***
Fat mass percentage (7 months) 6.4 ± 1.1 14.9 ± 4.6 ***
Open in a new tab

The values are reported as the mean ± SD; ***p < 0.001; n = 8 animals/group.

Oxidative stress in hepatic tissues

OS has been evaluated by superoxide anions levels (O2 •−), DNA damage and protein expression of antioxidant defenses. Livers from the OF group compared with those from the NF group at 7 months of life showed a significantly increased O2 •− production as determined by chemiluminescence (OF vs. NF (A.U. ± SD) 23.09 ± 0.60 vs. 6.82 ± 0.28; p < 0.001) (Fig. 1A) and decreased catalase (CAT) (−39%; p < 0.01) (Fig. 1B) and superoxide dismutase Cu/Zn (SOD Cu/Zn) (−23%; p < 0.05) (Fig. 1C) levels. Glucose-6 phosphate dehydrogenase (G6PDH) protein expression was highly increased (+140%; p < 0.001) (Fig. 1D).

Figure 1.

Figure 1

Open in a new tab

Hepatic oxidative stress in the NF and OF groups at 7 months of life. Superoxide anion production was measured by hydroethidine staining (A) at the same magnification (20x) in the OF (A-A) and NF (A-E) groups or without hydroethidine in the OF (A-C) and NF (A-G) groups. Nuclei were counterstained with DAPI (blue) (A-B, A-D, A-F, A-H). Hydroethidine fluorescence intensity was quantified using ImageJ (NF (white) and OF (grey)). Hepatic protein levels of CAT (B), SOD Cu/Zn (C) and G6PDH (D) were measured by western blot in the NF (white) and OF (gray) groups. Cropped blots are displayed. Representative images are presented and full-length western blots are presented in supplemental data 1. The values are reported as the mean ± SD; *p < 0.05; **p < 0.01; ***p < 0.001; n = 8 animals/group.

Oxidative DNA damage was evaluated by chemiluminescence using 53BP-1 staining in adult animals (Fig. 2). Livers from the OF group compared with those from the NF group showed increased DNA damage as characterized by increased 53BP-1 staining (OF vs. NF (A.U. ± SD): 19.20 ± 0.26 vs. 14.25 ± 0.16; p < 0.001) (Fig. 2A vs. E).

Figure 2.

Figure 2

Open in a new tab

Hepatic oxidative DNA damage in the NF and OF groups at 7 months. Oxidative DNA damage was evaluated using 53BP-1 staining at the same magnification (20x) in the OF (A) and NF (E) groups. Nuclei were counterstained with DAPI (blue) (B and F). Negative control was included in OF (C) and NF (G) groups, and nuclei were counterstained with DAPI (D and H). These pictures are representative images from n = 8 animals/group.

At PND 24, O2 •− production in the liver was similar between the two groups (OF vs. NF (A.U. ± SD): 1.87 ± 0.09 vs. 1.85 ± 0.11; p > 0.05) (Fig. 3A). No difference in CAT (Fig. 3B), SOD Cu/Zn (Fig. 3C) or G6PDH (Fig. 3D) proteins expression was observed.

Figure 3.

Figure 3

Open in a new tab

Hepatic oxidative stress in the NF and OF groups at PND 24. Superoxide anion production was measured by hydroethidine staining (A) at the same magnification (20x) in the OF (A-A) and NF (A-E) groups or without hydroethidine in the OF (A-C) and NF (A-G) groups. Nuclei were counterstained with DAPI (blue) (A-B, A-D, A-F, A-H). Hydroethidine fluorescence intensity was quantified using ImageJ (NF (white) and OF (gray)). These pictures are representative images from n = 8 animals/group. Hepatic protein levels of CAT (B), SOD Cu/Zn (C) and G6PDH (D) were measured by western blot in the NF (white) and OF (gray) groups. Cropped blots are displayed. Representative images are presented and full-length western blots are presented in supplemental data 2. The values are reported as the mean ± SD; p > 0.05; n = 7–8 animals/group.

Senescence in hepatic tissue

Hepatic senescence was investigated via western blot by measuring the protein expression of p21WAF, p53, Ac-p53, p16 INK4a, p-Rb/Rb and SIRT-1, which are considered senescence markers. At 7 months of life, livers from the OF group compared with those from the NF group showed increased levels of p21WAF (+60%; p < 0.001) (Fig. 4A), p53 (+60%; p < 0.001) (Fig. 4C), Acp53 (+43%; p < 0.05) (Fig. 4D), and p16INK4a (+41%; p < 0.05) (Fig. 4E) expression. In contrast, the protein expression of pRb/Rb, (−21%; p < 0.05) (Fig. 4F) and SIRT-1 (−31%; p < 0.01) (Fig. 4B) was decreased. No differences were observed between the OF and NF groups at PND 24 in expression levels of p21WAF (Fig. 5A), SIRT-1 (Fig. 5B), p53 (Fig. 5C), Acp53 (Fig. 5D), p16INK4a (Fig. 5E), and pRb/Rb (Fig. 5F).

Figure 4.

Figure 4

Open in a new tab

Hepatic senescence in the NF and OF groups at 7 months of life. Liver protein levels of p21WAF (A), SIRT-1 (B), p53 (C), Ac-p53 (D), p16INK4a (E) and pRb/Rb (F) were measured by western blot in the NF (white) and OF (gray) groups. Cropped blots are displayed. Representative images are presented and full-length western blots are presented in supplemental data 1. The values are reported as the mean ± SD; *p < 0.05; **p < 0.01; ***p < 0.001; n = 7–8 animals/group.

Figure 5.

Figure 5

Open in a new tab

Hepatic senescence in the NF and OF groups at PND 24. Liver protein levels of p21WAF (A), SIRT-1 (B), p53 (C), Ac-p53 (D), p16INK4a (E) and pRb/Rb (F) were measured by western blot in the NF (white) and OF (gray) groups. Cropped blots are displayed. Representative images are presented and full-length western blots are presented in supplemental data 2. The values are reported as the mean ± SD; p > 0.05; n = 6–8 animals/group.

Liver structure

Liver structure has been evaluated using histological staining (Figs 6, 7, 8) at PND 24 and 7 months of life. By 7 months of life, hepatic structure the OF group was suggestive of dysfunction. Livers from the OF group compared with those from the NF group exhibited a mild to moderate microsteatosis (Fig. 6D vs. C) upon hematoxylin and eosin (H&E) staining. Hepatic fibrosis was identified using Masson’s Trichrome staining in livers from the OF group compared with those from the NF group (Fig. 7A,C vs. B) and fibrosis was quantified using ImageJ. We observed increased fibrotic areas in the OF group compared with the NF group (OF vs. NF (A.U. ± SD) 4.69 ± 0.41 vs. 0.22 ± 0.03; p < 0.001) (Fig. 7A,D vs. A). Hepatic fibrosis was confirmed by increased alpha-SMA (α-SMA) protein levels in livers from the OF group compared to the NF group (+30%, p < 0.05) (Fig. 7B). At PND 24, histological analyses did not show differences between the two groups (Figs 6A vs. B and 8).

Figure 6.

Figure 6

Open in a new tab

Hematoxylin and eosin staining in liver from the NF and OF groups at PND 24 and 7 months of life. Basic liver histology was observed by staining with hematoxylin (nuclear localization) and eosin (cytoplasmic localization) in the NF (A) and OF (B) groups at 20x at PND 24 and in the NF (C) and OF (D) groups at 40x at 7 months of age. Slight microsteatosis was observed (arrow) only at 7 months of life in OF (D) vs. NF (C) groups. These images are representative from n = 8 animals/group.

Figure 7.

Figure 7

Open in a new tab

Hepatic fibrosis in the NF and OF groups at 7 months of life. Hepatic fibrosis was evaluated with Masson’s Trichrome at 10x in the NF (A-B) and OF (A-C) groups. A “stack image” was generated from NF (A-B) and OF (A-C) groups, respectively (A-A) and (A-D), to quantify the fibrotic area using ImageJ. A specific zone was enlarged at 20x in the NF (A-E) and OF (A-F) groups. ***p < 0.001. These images are representative from n = 8 animals/group. Alpha-SMA (α-SMA) protein expression was measured by western blot in the NF (white) and OF (gray) groups (B). Cropped blots are displayed. Representative images are presented and full-length western blots are presented in supplemental data 1. The values are reported as the mean ± SD; *p < 0.05; n = 7 animals/group.

Figure 8.

Figure 8

Open in a new tab

Hepatic fibrosis in the NF and OF groups at PND24. Hepatic fibrosis was evaluated with Masson’s Trichrome at 10x in the NF (B) and OF (C) groups. A “stack image” was generated from NF (B) and OF (C) groups, respectively (A) and (D), to quantify the fibrotic area using ImageJ. A specific zone was enlarged to 20x in the NF (E) and OF (F) groups. These images are representative from n = 8 animals/group. p > 0.05.

Histological detection of senescence

At 7 months of life, the cytoplasmic accumulation of highly oxidized insoluble proteins, known as lipofuscin, was evaluated in livers from the OF group compared with those from the NF group. Such proteins are diastase periodic acid-Schiff (d-PAS) resistant (Fig. 9D vs. C). They were characterized by increased Fontana-Masson staining (OF vs. NF (A.U. ± SD) 6.92 ± 0.22 vs. 1.80 ± 0.06; p < 0.001) (Fig. 10H vs. D and J) and Sudan Black B (SBB) staining (OF vs. NF (A.U. ± SD) 2.72 ± 0.24 vs. 0.46 ± 0.16; p < 0.001) (Fig. 11H vs. D and J). At PND 24, we did not find differences between livers from NF and OF groups regarding d-PAS (Fig. 9B vs. A), Fontana-Masson (OF vs. NF (A.U. ± SD) 1.58 ± 0.08 vs. 1.61 ± 0.08; p > 0.05) (Fig. 10F vs. B and I) or SBB (OF vs. NF (A.U. ± SD) 0.21 ± 0.01 vs. 0.22 ± 0.01; p > 0.05) (Fig. 11F vs. B and I) staining.

Figure 9.

Figure 9

Open in a new tab

Diastase periodic acid-Schiff (d-PAS) staining in livers from the NF and OF groups at PND 24 and 7 months of life. Livers from the NF and OF groups were stained with d-PAS at PND 24 (A and B, respectively) (20x) and at 7 months of life (C and D, respectively) (40x). These images are representative from n = 8 animals/group.

Figure 10.

Figure 10

Open in a new tab

Lipofuscin staining with Fontana-Masson in liver from the NF and OF groups at PND 24 and 7 months of life. Lipofuscin staining was evaluated with Fontana-Masson at PND 24 in the NF (A) and OF (E) groups (20x) and at 7 months of life in the NF (C) and OF (G) groups (40x). A “stack image” was generated from NF (B) and OF (F) groups at PND 24 and from NF (D) and OF (H) groups at 7 months of life to quantify the stained structure area using ImageJ. The results are reported as the percentage of lipofuscin staining area of the total area. ***p < 0.001. These images are representative from n = 8 animals/group.

Figure 11.

Figure 11

Open in a new tab

Lipofuscin staining with Sudan Black B in liver from the NF and OF groups at PND 24 and 7 months of life. Lipofuscin staining was evaluated with Sudan Black B at PND 24 in the NF (A) and OF (E) groups (40x) and at 7 months of life in the NF (C) and OF (G) groups (40x). A “stack image” was generated from NF (B) and OF (F) groups at PND 24 and from NF (D) and OF (H) groups at 7 months of life to quantify the stained structure area using ImageJ. The results are reported as the percentage of lipofuscin staining area of total area. ***p < 0.001. These images are representative from n = 8 animals/group.

Glucose tolerance and insulin tolerance test (GTT and ITT)

To assess the glucose tolerance and insulin resistance of the OF and NF groups, intraperitoneal glucose and insulin tests were performed at 6 months of life. Blood glucose concentrations were higher in OF mice than in NF mice early after glucose injection (Fig. 12A) (p < 0.05), and the area under the curve (AUC) of the blood glucose concentration was significantly greater in the OF group than in the NF group (Fig. 12B) (p < 0.05), indicating altered tolerance to glucose in this group. The ITTs revealed a lower decrease in blood glucose in the OF group (Fig. 12C,D) (p < 0.05), corresponding to insulin resistance in this group.

Figure 12.

Figure 12

Open in a new tab

Intraperitoneal glucose and insulin tolerance tests at 6 months of age in the NF and OF groups. Evolution of blood glucose (A,C) and the area under the curve for blood glucose (B,D) after 2 g/kg glucose (A,B) or 0.75 IU/kg insulin (C,D) was intraperitoneally administered in the NF (black) and OF (white) groups. The values are reported as the mean ± SD; *p < 0.05; n = 8 animals/group.

Insulin signaling in the liver

The expression levels of the insulin-signaling molecules pIRS-1/IRS-1, pIRS-2/IRS-2, Akt, PI3K, and pAkt/Akt were measured by western blot in livers from both the OF and NF groups. At 7 months of life, the livers from the OF group compared with those from the NF group showed decreased protein expression of pIRS-1/IRS-1 (−22%; p < 0.01) (Fig. 13A), pIRS-2/IRS-2 (−23%; p < 0.05) (Fig. 13B), PI3K (−25%; p < 0.01) (Fig. 13C), and pAkt/Akt (−74%; p < 0.001) (Fig. 13D). At PND 24, protein expression levels of pIRS-1/IRS-1 (Fig. 14A), pIRS-2/IRS-2 (Fig. 14B), PI3K (Fig. 14C), and pAkt/Akt (Fig. 14D) were similar between the two groups.

Figure 13.

Figure 13

Open in a new tab

Liver insulin signaling and glucose transporter levels in the NF and OF groups at 7 months of life. Liver protein levels of pIRS-1/IRS-1 (A), pIRS-2/IRS-2 (B), PI3K (C), pAkt/Akt (D), GLUT-4 (E), GLUT-2 (F) were measured by western blot in the NF (white) and OF (gray) groups. Cropped blots are displayed. Representative images are presented and full-length western blots are presented in supplemental data 1. The values are reported as the mean ± SD; *p < 0.05; **p < 0.01; ***p < 0.001; n = 7–8 animals/group.

Figure 14.

Figure 14

Open in a new tab

Liver insulin signaling and glucose transporter levels in the NF and OF groups at PND 24. Liver protein levels of pIRS-1/IRS-1 (A), pIRS-2/IRS-2 (B), PI3K (C), pAkt/Akt (D), GLUT-4 (E), GLUT-2 (F) were measured by western blot in the NF (white) and OF (gray) groups. Cropped blots are displayed. Representative images are presented and full-length western blots are presented in supplemental data 2. The values are reported as the mean ± SD; p > 0.05; n = 6–8 animals/group.

Glucose transporters in the liver

The expression levels of the glucose transporters GLUT-4 and GLUT-2 were measured by western blot. At 7 months of life, livers from the OF group compared with those from the NF group showed decreased GLUT-2 protein expression (−30%; p < 0.01) (Fig. 13F), whereas GLUT-4 protein expression was increased (+27%; p < 0.01) (Fig. 13E). At PND 24, no differences in GLUT-2 (Fig. 14F) or GLUT-4 (Fig. 14E) proteins expression were observed between the two groups.

Discussion

Clinical and experimental studies have shown that an altered nutritional environment during critical developmental periods contributes to the later development of metabolic disorders. Early exposure to suboptimal postnatal overnutrition, to maternal undernutrition or overnutrition, or to an imbalanced maternal diet can impair metabolic programming and therefore lead to the development of metabolic syndrome and related diseases at adulthood16. Many organs and systems have been identified as being sensitive to nutritional programming, notably, the liver. The liver is involved in protein, lipid and glucose homeostasis and therefore is particularly susceptible to OS-induced damage, including hepatocyte senescence, which has been linked to both acute and chronic liver diseases. However, the involved mechanisms remain unknown. In this study, using a transient postnatal OF mouse model induced by litter size reduction during the lactation period, we show that early excess nutrition during lactation period is associated with increased liver OS, accelerated hepatocyte senescence and altered hepatic structure and function.

We observed an increased OS in adult livers from the OF group compared with those from the NF group, characterized by increased O2 •− production and decreased CAT and SOD Cu/Zn protein expression levels as mentioned in other animal model of obesity25. Redox homeostasis is also regulated by G6PDH. In adipocytes, G6PDH overexpression has been shown to stimulate OS and promote the expression of pro-oxidative enzymes, mainly NADPH oxidase, which is responsible for the production of ROS and, notably, O2 •− 26. Livers from the OF group showed G6PDH overexpression at adulthood, a situation that has been observed in other animal models of obesity27 and which could therefore contribute to increase O2 •− production observed in this group. OS can induce DNA damage28. 53BP-1 is a protein involved in double-stranded break repair, and has been found to be elevated in many DNA damage response conditions29. We observed an increased 53BP-1 staining in livers from the OF group at 7 months of life, suggesting that transient postnatal OF appears to be associated with double-stranded DNA breaks in the liver induced by OS, which could contribute to the development of liver disease. Indeed, in patients with chronic liver disease, hepatic oxidative DNA damage, measuring by 8-hydroxy-2′-deoxyguanosine accumulation has been described30. This study shows the breaks induced by OS secondary to transient postnatal overnutrition. We investigated whether OS was also present earlier in life. At PND 24, we observed no differences between the OF and NF groups concerning liver O2 •− production and CAT, SOD Cu/Zn and G6PDH protein expression levels. These data are consistent with the latency period between the early stimulus and the later consequence, characteristic of altered developmental programming.

Excessive ROS levels and impaired DNA damage repair can contribute to premature cellular senescence and accelerated aging31 and are associated with metabolic and liver dysfunctions. We observed SIPS in livers from OF group, based on a multi-marker approach. Senescence being a multi-factorial process, and measurement of β-galactosidase (SA-β-gal) activity, the most extensively used biomarker of cellular senescence32, being impossible in the fixed preparations we used in the study, we chose to use the accumulation of lipofuscine as a marker of highly oxidized insoluble proteins and of senescence33,34 and found a lipofuscin accumulation in livers from 7-month-old OF mice. Lipofuscin staining has been proposed as a senescence biomarker, particularly for SIPS, comparable to SA-β-gal activity35, and has been associated with chronic OS34. We observed at adulthood increased p53, p21WAF, and p16INK4a expression and reduced pRb/Rb expression as observed in chronic liver disease36. Transactivation of the p53 pathway37 and the cyclin-dependent kinase inhibitors p21WAF and p16INK4a  38 inhibits cyclin-dependent kinases, thereby preventing the phosphorylation of pRb, resulting in the silencing of genes involved in proliferation. An increased p16INK4a protein expression could be linked to higher O2 •− levels observed in OF group. Indeed, upregulated p16INK4a protein level has been observed in melanocytes treated with ROS (hydrogen peroxide), and this upregulation was blocked by pretreatment with the antioxidant N-acetylcysteine39, thus confirming the association between p16INK4a upregulation and OS. Furthermore, the activation of p53 and p16INK4a signaling has been reported in aged vessels, the visceral fat of obese individuals, as well as in aging rodent models, which could contribute to the progression of cardiovascular and metabolic disorders40–42.

The control of cellular senescence involves another family of proteins called sirtuins43. Sirtuins, that are collectively referred as deacylases, are a group of seven highly conserved proteins (SIRT-1 to SIRT-7) controlling the dynamic structure and function of chromatin; these proteins are divided into three classes based on homology with the yeast proteins Rpd3 (class I), Hda1 (class II) and Sir 2 (class III)44. Sir2 promotes the increase in life span induced by caloric restriction. SIRT-1 is the closest homolog to Sir2 and the best understood in terms of cellular activity and function, particularly in the regulation of cellular lifespan. An overexpression of SIRT-1 alone45 or the co-overexpression of SIRT-1 with nicotinamide phosphoribosyltransferase46 has been shown to delay cellular senescence, whereas inhibiting SIRT-1 expression and/or activity leads to premature cellular senescence47. Livers from the OF group showed a decreased SIRT-1 expression at adulthood compared with those from the NF group. Acetylation of p53 at Lys-382, a target of SIRT-1, was significantly higher in the OF group, suggesting an overall reduction in SIRT-1 activity48. Similar observations have been made in adipose tissue from OF mice49 and in primary cultures of senescent mouse hepatocytes50. OS, and notably ROS, can modulate SIRT-1 expression and activity51. Therefore, an increased superoxide anion production observed in OF group could explain the reduced SIRT-1 expression and activity observed in this group. Increased p16INK4a expression with reduced Rb phosphorylation blocking the entry of proliferating cells into the S phase and decreased SIRT-1 protein expression and activity indicate that transient postnatal OF is associated with adult SIPS rather than with replicative senescence48. We also searched for signs of senescence earlier in life. At PND 24, no differences were observed in lipofuscin staining as well as in the protein levels of p53, Acp53, p21, p16INK4a, pRb/Rb and SIRT-1 between the OF and NF groups, indicating the absence of SIPS at an age where OS was absent, confirming the association between OS and SIPS.

On the other hand, this study demonstrates that transient, spontaneous OF during lactation period led to increased body weight at weaning (PND 24), which persisted to a lesser extent to adulthood, and a major increase in fat mass. Hepatic steatosis is an important structural alteration associated with obesity52. Obesity increases lipid delivery to the liver from both the diet and adipose tissue53. We observed the presence of a mild microsteatosis in livers from the OF group compared with those from the NF group only at adulthood, which could be the consequence of OS, notably decreased SOD and CAT expression levels as observed in a rat model of early postnatal overnutrition25, and also due to the higher percentage of fat mass observed in this group. Liver steatosis can be associated with OS caused by the lipid overload54 and decreased antioxidant enzymes activity25,55. Hepatic microsteatosis and macrosteatosis can be inter-converted56. At the time points in our study, we observed only a mild microsteatosis at 7-month-old OF mice and we can only speculate about a possible later transition to macrosteatosis with increasing age. Liver steatosis is an important factor that may determine the rate of fibrosis progression in a range of liver diseases. Hepatocytes from the OF group, compared with those from the NF group, showed an hepatic fibrosis at adulthood characterized by increased Masson’s Trichrome staining and alpha-SMA protein expression, a useful marker of the earliest stages of hepatic fibrosis57. Increased liver fibrosis could be a consequence of increased p53, p16INK4a expression58 and decreased SIRT-1 activity/ expression59 that we observed in OF group.

Transient, spontaneous OF during the lactation period has been also associated with the development of subsequent metabolic disorders at adulthood. We observed in OF group at 7 months of age an impaired glucose tolerance and insulin resistance. Similar data have been reported in young OF mice at weaning60, and in adult OF rats6,14. Aging in humans and in animal studies has also been associated with the loss of insulin sensitivity61. Insulin resistance in liver has been associated with reduced expression of both major IRS-1 and IRS-2 proteins62, and with alteration in signaling through the IRS proteins, which coordinate various signals regulating cell growth, survival, and metabolism, notably via activation of the PI3K-Akt cascade63. We observed, only at adulthood, that livers from the OF group compared with those from the NF group, showed alterations in insulin-signaling pathway with reduced pIRS-1/IRS-1, pIRS-2/IRS-2, pAkt/Akt and PI3K protein expressions which could be associated with the insulin resistance and glucose intolerance observed in this group. Similar data have been observed in a rat postnatal OF model25 associated with OS and in Zucker fatty rats64.

An important limitation in our study is that the livers from OF and NF groups were collected in a fasting condition, while insulin-signaling changes are more accurately evaluated under stimulated conditions. Although our results are significant even in the absence of postprandial stimulation, they should be carefully interpreted. Glucose is the main stimulus for insulin secretion. Glucose enters cells by means of several glucose transporter proteins (GLUTs) in an ATP-independent manner. GLUT-4 plays a major role in glucose transport in adipose tissue and striated muscle and, consequently, in its metabolism. In the liver, however, GLUT-4 levels are considered very low and not relevant to hepatic insulin signaling. On the contrary, GLUT-2 is highly expressed in liver and does not undergo insulin-stimulated translocation65. We measured only the total hepatic levels of GLUT-4 and GLUT-2. At 7 months of life, in livers from the OF group compared with those from NF group, we observed an unexpected increase in total GLUT-4 protein and a decrease in GLUT-2 protein expression levels. While no conclusion can be drawn regarding the consequences of increased GLUT-4 signaling in the liver, a decrease in GLUT-2 protein expression may lead to alter insulin signaling in the liver. Recently, data have suggested that changes in GLUTs expression levels may be surrogate markers of hepatocyte senescence and may be associated with liver disease66. SIRT-1 plays a major role in the regulation of hepatic metabolism through its deacylase activity and via its direct and indirect involvement in insulin signaling67. SIRT-1 deficiency has been linked to hepatic glucose overproduction and chronic hyperglycemia68, as well as insulin resistance and metabolic syndrome69. Therefore, impaired SIRT-1 expression and activity could be associated with the metabolic disorders observed in the OF group at adulthood. No difference appeared between the groups concerning the expression of these two glucose transporters at PND 24.

In conclusion, this study demonstrates that transient postnatal OF leads to OS-induced hepatocyte SIPS associated with decreased SIRT-1 activity and expression at adulthood. We included in this study only males and therefore, it would be interesting to observe whether early transient postnatal OF during lactation period could have a gender effect on hepatic disorders described in this study. The reduced SIRT-1 functionality could be the consequence of OS and is likely linked to hepatic fibrosis, microsteatosis and impaired hepatic insulin signaling and glucose transporters, leading to insulin resistance and glucose intolerance observed at adulthood. Such hepatic dysfunctions could be a mark of later associated with the development of non-alcoholic fatty liver disease. Therefore, modulating SIRT-1 expression using resveratrol or caloric restriction may be a potential intervention in view of reversing hepatic dysfunctions at adulthood, secondary to altered metabolic programming induced by a transient early postnatal OF. The results of this study also demonstrate that a transient postnatal OF on breast milk is responsible for major changes in body composition and glucose/insulin metabolic characteristics. They suggest that early nutrition has a particular importance during the period developmental programming in early infancy.

Methods

Animal model

Investigations were performed in accordance with Directive 2010/63/EU of the European Parliament and the Guidelines for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85–23, revised 1996). The Comité d’Ethique de l’Experimentation Animale, Université de Bourgogne-Franche-Comté, Dijon, France, acted as the institutional review board (protocol agreement number: 00412.03) and specifically approved this study. Throughout the procedure, care was taken to avoid animal suffering and to ensure animal welfare, e.g., by improving the cage environment. Throughout the protocol, no animal died from the treatment or became moribund such that early sacrifice was necessary. We did not observe specific signs of pain or distress (e.g., abnormal animal behavior, decreased food or water consumption, prostration) throughout the study.

Adult female C57BL/6 mice (Charles River, L’Arbresle, France) from 6 weeks of age were individually housed. After one week of adaptation, they were mated overnight with males at a proportion of 2:1. The females were then housed in individual cages for gestation and lactation and had free access to tap water. They were kept on a standard pellet diet (A03, SAFE Diets Augy, France) under a 12-h light-dark cycle in a room maintained at a controlled temperature of 22 °C and constant humidity. On the third day of life, male pups were randomly distributed among mothers to achieve cross fostering. Litter sizes were adjusted to 9 male pups for NF or reduced to 3 male pups to induce postnatal OF in the lactation period, thereby forming the NF and OF groups. Each litter included pups from one to six different dams to increase genetic variability within the litters. Excess pups were rapidly sacrificed by decapitation after a brief period of isoflurane anesthesia. After weaning, on PND 24, the mice in both groups had free access to a standard diet (A04, SAFE Diets Augy, France) and water. Throughout the life of the mice, body weight and food intake were measured weekly and then monthly.

Males (NF group, n = 8; OF group, n = 8) were specifically studied at PND 24 and at 7 months of age. For histological studies and evaluation of OS and accelerated senescence, mice were anesthetized after 6 h of fasting by an intraperitoneal injection of sodium pentobarbital (80 mg/kg). The liver was then harvested and immediately frozen/fixed in liquid nitrogen/formol until further processing.

Glucose and insulin tolerance tests (GTTs and ITTs)

Intraperitoneal GTTs and ITTs were performed after a 5-h fasting period in a separate group of awake mice aged 6 months. GTTs consisted in an intraperitoneal injection of glucose (2 g/kg). Blood droplets were collected from the tail vein just prior to the glucose injection (time 0) and at 15, 30, 45, 60, 75, 90, 105 and 120 min following the injection. The blood glucose concentrations were measured using a glucometer and FreeStyle Optium test strips (Abbott, Santa Clara, CA, USA). For the ITTs, mice were injected with 0.75 IU/kg human recombinant insulin (Actrapid®, Novo Nordisk, France), and blood glucose concentration was determined at 0, 15, 30, 45, 60, 75, 90, 105 and 120 min thereafter. The data of GTT and ITT are represented as blood glucose concentration in mg/dL.

Western blotting

Liver proteins from NF (n = 8) and OF (n = 8) groups were extracted at PND 24 and at 7 months of life (from the medial lobe of the snap-frozen livers) using 500 μl of RIPA buffer (pH 7.4, Tris–HCl 50 mM, NP-40 1%, sodium deoxycholate 0.25%, NaCl 150 mM, EDTA 1 mM, NaF 50 mM, Na3VO4 1 mM and beta-glycerophosphate 25 mM) (Sigma-Aldrich, St. Louis, MO, USA). Prior to tissue homogenization, a mini protease inhibitor tablet (Roche Diagnostics, Indianapolis, IN, USA) was added to the lysis buffer. Homogenized tissue was left on ice for 5 min and then sonicated. Following sonication, the homogenate was centrifuged for 25 min at 14,000 rpm and 4 °C. The supernatant was retained for protein quantification (Pierce BCA Protein Assay Kit, Thermo Scientific, Rockford, IL, USA) and western blot analysis.

Denatured (10 min at 70 °C) liver proteins (20 μg) from the NF and OF groups were separated on the same gradient gel (NuPAGE 4–12% Bis-Tris gel, Thermo Scientific) and transferred for 2 h at room temperature to Whatman nitrocellulose membranes (Thermo Scientific). Ponceau staining (Thermo Scientific) confirmed the presence of proteins on the membranes. All primary antibody incubations were performed in blocking buffer (TBS-Tween 2%-bovine serum albumin (BSA) 3%) overnight at 4 °C. Antibodies against the insulin receptor substrates 1 and 2 (IRS-1, IRS-2), phospho-IRS-1 (pIRS-1), PI3 kinase (PI3K), phospho-Akt (Ser473) (pAkt), Akt, SOD Cu/Zn, catalase (CAT), glucose transporter-4 (Glut-4), glucose transporter-2 (Glut-2; Abcam Ltd., Cambridge, UK), SIRT-1, retinoblastoma tumor suppressor protein (Rb) and phospho-Rb (Ser807/811) (pRb), p21WAF, p53 and acetyl-p53 (Lys382), CDKN2A/p16INK4a and pIRS-2 (Abcam), glucose-6-phosphate dehydrogenase (G6PDH; Cell Signaling Technology (Danvers, MA, USA)) and alpha-smooth muscle actin (α-SMA; Sigma-Aldrich) were purchased and used at the dilutions recommended for immunoblotting (1:1000). Incubations with anti-mouse or anti-rabbit secondary antibodies (1/2000; Cell Signaling) were performed for 1 h at room temperature in blocking buffer (TBS-Tween 2%-BSA 3%). The antibodies were visualized using enhance chemiluminescence western blotting substrate (Thermo Scientific). A G-BOX Imaging System (GeneSys, Syngene, Cambridge, UK) was used to detect specific bands, and the optical density of each band was measured using specific software (GeneTools, Syngene) for all blots. However, for pRb/Rb, pAkt/Akt and SOD Cu/Zn, pIRS-2/IRS-2 proteins detection at 7 months of life, the revelation has been realized using photographic film (CL-XPosure TM Film, Thermo Scientific), scanned and the optical density of each band was measured using specific software (GeneTools). Representative experiments are shown for each protein.Full-length western blots are represented in supplementary information (supplemental data 1 and 2).

Superoxide anion (O2•−) detection using chemiluminescence

Liver O2 •− production was evaluated in NF (n = 8) and OF (n = 8) groups at PND 24 and at 7 months of life using the oxidative fluorescent dye hydroethidine (2 μM, Sigma-Aldrich)70 in comparisons to negative control (autofluorescence detection). In the presence of O2 •−, hydroethidine is oxidized to fluorescent ethidium bromide, which is trapped in DNA by intercalation. Deparaffinized hepatic sections (5-μm thick) were stained with hydroethidine by incubating in a light-protected humidified chamber at 37 °C for 30 min. The sections were rinsed with phosphate-buffered saline (PBS; 2 times for 10 min) and mounted using Fluoromount-G mounting medium with 4′6-diamidino-2-phenylindole (DAPI; Interchim, France). Images were obtained using a laser scanning confocal microscope (Leica SP5) equipped with an argon laser. Fluorescence was detected from at least 4 hepatic sections per animal with a 514-nm long-pass filter and evaluated with ImageJ software (http://rsbweb.nih.gov/ij), and autofluorescence of liver was subtracted.

Oxidative DNA damage detection

Deparaffinized liver sections (5-μm thick) from 7-month-old mice in the NF (n = 8) and OF (n = 8) groups were stained with 53BP-1 (1/100, Abcam) overnight at 4 °C. The sections were then washed with 1x PBS (2 times for 10 min) and incubated for 1 h with Alexa Fluor-488-conjugated donkey anti-rabbit IgG (1/200, Abcam). The sections were then rinsed with 1x PBS (2 times for 10 min) and mounted using Fluoromount-G mounting medium with DAPI (Interchim). A negative control was obtained using incubation only with secondary antibody. Fluorescence from at least 4 hepatic sections per animal was evaluated using ImageJ software.

Histological analysis

At PND 24 and 7 months, livers from NF (n = 8) and OF (n = 8) groups were rapidly removed and fixed for 24–48 h in 4% formol. Equatorial cross-sections were paraffin-embedded, and 5-μm sections were stained with H&E for the hepatic structure evaluation. In addition, livers were stained with Masson’s Trichrome to evaluate hepatic fibrosis. For all histological analyses, three images were captured for each animal. A pathologist (Prof. C. Sempoux) confirmed the histological observations. Hepatic fibrosis was quantified using ImageJ software. A quantitative analysis was performed by a single examiner (C.Y). For each image in OF and NF groups, a “stack image” was generated, and a color threshold was applied to identify the stained structure. The results are reported as the percentage of fibrotic area of total area.

Histological detection of cell senescence

The presence of cytoplasmic accumulation of highly oxidized insoluble proteins, known as lipofuscin staining has been considered a marker of SIPS35. Lipofuscin staining was identified using the following histological analyses: d-PAS, Fontana-Masson and SBB staining. For all histological analyses, three images were captured for each animal. Lipofuscin staining was quantified using ImageJ software. A quantitative analysis was performed by a single examiner (C.Y). For Fontana-Masson and SBB staining, each image in OF and NF groups, a “stack image” was generated, and a color threshold was applied to identify the stained structure. The results are reported as the percentage of lipofuscin area of total area.

Statistical analyses

All data were presented as mean ± SD. Experimental observations were analyzed using Mann-Whitney U test (western blot) and student t test. GraphPad Prism 7 (La Jolla, CA, USA) was used for performing statistical analyses and creating graphics. The significance level was set at p < 0.05.

Data availability

All data generated or analysed during this study are included in this published article.

Electronic supplementary material

Full-length blots (1.9MB, pdf)

Acknowledgements

The authors gratefully thank the Mouse Pathology Institute, Prof Christine Sempoux, Dr. Anne Christine Peyter and Prof. Pedrazzini’s lab at CHUV/UNIL for the provided technical assistance. This work was supported by grants from the French Ministry of Research and the Institut National de la Santé et de la Recherche Médicale (INSERM), and CHUV-University of Lausanne, Switzerland.

Author Contributions

Study conception and design: C.Y., U.S. and C.V. Data acquisition: C.Y., N.L., D.M., M.B., B.K. and K.N. Data analysis and interpretation: C.Y., N.L., H.C., J.B.A., U.S., M.B. and C.V. Manuscript drafting: C.Y., J.B.A., B.S., U.S., M.B. and C.V.

Competing Interests

The authors declare that they have no competing interests.

Footnotes

Catherine Vergely and Umberto Simeoni contributed equally to this work.

Electronic supplementary material

Supplementary information accompanies this paper at doi:10.1038/s41598-017-11756-2

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Must A, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–1529. doi: 10.1001/jama.282.16.1523. [DOI] [PubMed] [Google Scholar]
  • 2.Pi-Sunyer FX. The medical risks of obesity. Obes Surg. 2002;12(Suppl 1):6S–11S. doi: 10.1007/BF03342140. [DOI] [PubMed] [Google Scholar]
  • 3.de Onis M, Blossner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 2010;92:1257–1264. doi: 10.3945/ajcn.2010.29786. [DOI] [PubMed] [Google Scholar]
  • 4.Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes. 2006;1:11–25. doi: 10.1080/17477160600586747. [DOI] [PubMed] [Google Scholar]
  • 5.Barker DJ. The developmental origins of adult disease. J Am Coll Nutr. 2004;23:588S–595S. doi: 10.1080/07315724.2004.10719428. [DOI] [PubMed] [Google Scholar]
  • 6.Cunha AC, et al. Long-term effects of overfeeding during lactation on insulin secretion–the role of GLUT-2. J Nutr Biochem. 2009;20:435–442. doi: 10.1016/j.jnutbio.2008.05.002. [DOI] [PubMed] [Google Scholar]
  • 7.You S, Gotz F, Rohde W, Dorner G. Early postnatal overfeeding and diabetes susceptibility. Exp Clin Endocrinol. 1990;96:301–306. doi: 10.1055/s-0029-1211023. [DOI] [PubMed] [Google Scholar]
  • 8.Plagemann A, Heidrich I, Gotz F, Rohde W, Dorner G. Obesity and enhanced diabetes and cardiovascular risk in adult rats due to early postnatal overfeeding. Exp Clin Endocrinol. 1992;99:154–158. doi: 10.1055/s-0029-1211159. [DOI] [PubMed] [Google Scholar]
  • 9.Boullu-Ciocca S, et al. Postnatal diet-induced obesity in rats upregulates systemic and adipose tissue glucocorticoid metabolism during development and in adulthood: its relationship with the metabolic syndrome. Diabetes. 2005;54:197–203. doi: 10.2337/diabetes.54.1.197. [DOI] [PubMed] [Google Scholar]
  • 10.Davidowa H, Plagemann A. Hypothalamic neurons of postnatally overfed, overweight rats respond differentially to corticotropin-releasing hormones. Neurosci Lett. 2004;371:64–68. doi: 10.1016/j.neulet.2004.08.042. [DOI] [PubMed] [Google Scholar]
  • 11.Rodrigues AL, et al. Low expression of insulin signaling molecules impairs glucose uptake in adipocytes after early overnutrition. J Endocrinol. 2007;195:485–494. doi: 10.1677/JOE-07-0046. [DOI] [PubMed] [Google Scholar]
  • 12.Rodrigues AL, de Moura EG, Passos MC, Dutra SC, Lisboa PC. Postnatal early overnutrition changes the leptin signalling pathway in the hypothalamic-pituitary-thyroid axis of young and adult rats. J Physiol. 2009;587:2647–2661. doi: 10.1113/jphysiol.2009.169045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Li N, et al. Short-term moderate diet restriction in adulthood can reverse oxidative, cardiovascular and metabolic alterations induced by postnatal overfeeding in mice. Sci Rep. 2016;6:30817. doi: 10.1038/srep30817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Habbout A, et al. Postnatal overfeeding in rats leads to moderate overweight and to cardiometabolic and oxidative alterations in adulthood. Biochimie. 2012;94:117–124. doi: 10.1016/j.biochi.2011.09.023. [DOI] [PubMed] [Google Scholar]
  • 15.Habbout A, Li N, Rochette L, Vergely C. Postnatal overfeeding in rodents by litter size reduction induces major short- and long-term pathophysiological consequences. J Nutr. 2013;143:553–562. doi: 10.3945/jn.112.172825. [DOI] [PubMed] [Google Scholar]
  • 16.Duque-Guimaraes DE, Ozanne SE. Nutritional programming of insulin resistance: causes and consequences. Trends Endocrinol Metab. 2013;24:525–535. doi: 10.1016/j.tem.2013.05.006. [DOI] [PubMed] [Google Scholar]
  • 17.Qureshi K, Abrams GA. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2007;13:3540–3553. doi: 10.3748/wjg.v13.i26.3540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Meng R, Zhu DL, Bi Y, Yang DH, Wang YP. Anti-oxidative effect of apocynin on insulin resistance in high-fat diet mice. Ann Clin Lab Sci. 2011;41:236–243. [PubMed] [Google Scholar]
  • 19.Mari M, et al. Redox control of liver function in health and disease. Antioxid Redox Signal. 2010;12:1295–1331. doi: 10.1089/ars.2009.2634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Sonta T, et al. Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic Biol Med. 2004;37:115–123. doi: 10.1016/j.freeradbiomed.2004.04.001. [DOI] [PubMed] [Google Scholar]
  • 21.Bonomini F, Rodella LF, Rezzani R. Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis. 2015;6:109–120. doi: 10.14336/AD.2014.0305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961;25:585–621. doi: 10.1016/0014-4827(61)90192-6. [DOI] [PubMed] [Google Scholar]
  • 23.Toussaint O, Medrano EE, von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp Gerontol. 2000;35:927–945. doi: 10.1016/S0531-5565(00)00180-7. [DOI] [PubMed] [Google Scholar]
  • 24.Aravinthan A, et al. Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease. PLoS One. 2013;8:e72904. doi: 10.1371/journal.pone.0072904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Conceicao EP, et al. Oxidative stress programming in a rat model of postnatal early overnutrition–role of insulin resistance. J Nutr Biochem. 2013;24:81–87. doi: 10.1016/j.jnutbio.2012.02.010. [DOI] [PubMed] [Google Scholar]
  • 26.Spolarics Z. A carbohydrate-rich diet stimulates glucose-6-phosphate dehydrogenase expression in rat hepatic sinusoidal endothelial cells. J Nutr. 1999;129:105–108. doi: 10.1093/jn/129.1.105. [DOI] [PubMed] [Google Scholar]
  • 27.Park J, et al. Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity. Mol Cell Biol. 2005;25:5146–5157. doi: 10.1128/MCB.25.12.5146-5157.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Yzydorczyk C, et al. [Oxidative stress after preterm birth: origins, biomarkers, and possible therapeutic approaches] Arch Pediatr. 2015;22:1047–1055. doi: 10.1016/j.arcped.2015.05.019. [DOI] [PubMed] [Google Scholar]
  • 29.Joo WS, et al. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev. 2002;16:583–593. doi: 10.1101/gad.959202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Fujita N, et al. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. J Viral Hepat. 2008;15:498–507. doi: 10.1111/j.1365-2893.2008.00972.x. [DOI] [PubMed] [Google Scholar]
  • 31.Davalli P, Mitic T, Caporali A, Lauriola A, D’Arca D. ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age-Related Diseases. Oxid Med Cell Longev. 2016;2016:3565127. doi: 10.1155/2016/3565127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Lee BY, et al. Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell. 2006;5:187–195. doi: 10.1111/j.1474-9726.2006.00199.x. [DOI] [PubMed] [Google Scholar]
  • 33.Schmucker DL, Sachs H. Quantifying dense bodies and lipofuscin during aging: a morphologist’s perspective. Arch Gerontol Geriatr. 2002;34:249–261. doi: 10.1016/S0167-4943(01)00218-7. [DOI] [PubMed] [Google Scholar]
  • 34.Jung T, Bader N, Grune T. Lipofuscin: formation, distribution, and metabolic consequences. Ann N Y Acad Sci. 2007;1119:97–111. doi: 10.1196/annals.1404.008. [DOI] [PubMed] [Google Scholar]
  • 35.Georgakopoulou EA, et al. Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues. Aging (Albany NY) 2013;5:37–50. doi: 10.18632/aging.100527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Aravinthan A, et al. The senescent hepatocyte gene signature in chronic liver disease. Exp Gerontol. 2014;60:37–45. doi: 10.1016/j.exger.2014.09.011. [DOI] [PubMed] [Google Scholar]
  • 37.Schmitt CA, et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell. 2002;109:335–346. doi: 10.1016/S0092-8674(02)00734-1. [DOI] [PubMed] [Google Scholar]
  • 38.Stein GH, Drullinger LF, Soulard A, Dulic V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol. 1999;19:2109–2117. doi: 10.1128/MCB.19.3.2109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Jenkins NC, et al. The p16(INK4A) tumor suppressor regulates cellular oxidative stress. Oncogene. 2011;30:265–274. doi: 10.1038/onc.2010.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011;479:232–236. doi: 10.1038/nature10600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Minamino T, et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med. 2009;15:1082–1087. doi: 10.1038/nm.2014. [DOI] [PubMed] [Google Scholar]
  • 42.Krishnamurthy J, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest. 2004;114:1299–1307. doi: 10.1172/JCI22475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Donmez G, Guarente L. Aging and disease: connections to sirtuins. Aging Cell. 2010;9:285–290. doi: 10.1111/j.1474-9726.2010.00548.x. [DOI] [PubMed] [Google Scholar]
  • 44.Morris BJ. Seven sirtuins for seven deadly diseases of aging. Free Radic Biol Med. 2013;56:133–171. doi: 10.1016/j.freeradbiomed.2012.10.525. [DOI] [PubMed] [Google Scholar]
  • 45.Huang J, et al. SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts. PLoS One. 2008;3:e1710. doi: 10.1371/journal.pone.0001710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Ho C, van der Veer E, Akawi O, Pickering JG. SIRT1 markedly extends replicative lifespan if the NAD+ salvage pathway is enhanced. FEBS Lett. 2009;583:3081–3085. doi: 10.1016/j.febslet.2009.08.031. [DOI] [PubMed] [Google Scholar]
  • 47.Liu W, et al. High-affinity Na(+)-dependent dicarboxylate cotransporter promotes cellular senescence by inhibiting SIRT1. Mech Ageing Dev. 2010;131:601–613. doi: 10.1016/j.mad.2010.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Vassallo, P. F. et al. Accelerated senescence of cord blood endothelial progenitor cells in premature neonates is driven by SIRT1 decreased expression. Blood, 10.1182/blood-2013-02-484956 (2014). [DOI] [PubMed]
  • 49.Yoshizaki T, et al. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol. 2009;29:1363–1374. doi: 10.1128/MCB.00705-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Yu A, et al. Resistin impairs SIRT1 function and induces senescence-associated phenotype in hepatocytes. Mol Cell Endocrinol. 2013;377:23–32. doi: 10.1016/j.mce.2013.06.028. [DOI] [PubMed] [Google Scholar]
  • 51.Revollo JR, Li X. The ways and means that fine tune Sirt1 activity. Trends Biochem Sci. 2013;38:160–167. doi: 10.1016/j.tibs.2012.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Watanabe S, Yaginuma R, Ikejima K, Miyazaki A. Liver diseases and metabolic syndrome. J Gastroenterol. 2008;43:509–518. doi: 10.1007/s00535-008-2193-6. [DOI] [PubMed] [Google Scholar]
  • 53.Donnelly KL, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115:1343–1351. doi: 10.1172/JCI23621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Muoio DM, Newgard CB. Biomedicine. Insulin resistance takes a trip through the ER. Science. 2004;306:425–426. doi: 10.1126/science.1104680. [DOI] [PubMed] [Google Scholar]
  • 55.Bringhenti I, Ornellas F, Martins MA, Mandarim-de-Lacerda CA, Aguila MB. Early hepatic insult in the offspring of obese maternal mice. Nutr Res. 2015;35:136–145. doi: 10.1016/j.nutres.2014.11.006. [DOI] [PubMed] [Google Scholar]
  • 56.Stacchiotti A, et al. Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease. PLoS One. 2016;11:e0148115. doi: 10.1371/journal.pone.0148115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Carpino G, et al. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis. 2005;37:349–356. doi: 10.1016/j.dld.2004.11.009. [DOI] [PubMed] [Google Scholar]
  • 58.Jin H, et al. Activation of PPARgamma/P53 signaling is required for curcumin to induce hepatic stellate cell senescence. Cell Death Dis. 2016;7:e2189. doi: 10.1038/cddis.2016.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Tian XF, Ji FJ, Zang HL, Cao H. Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs. PLoS One. 2016;11:e0158657. doi: 10.1371/journal.pone.0158657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Du Q, et al. Postnatal weight gain induced by overfeeding pups and maternal high-fat diet during the lactation period modulates glucose metabolism and the production of pancreatic and gastrointestinal peptides. Peptides. 2015;70:23–31. doi: 10.1016/j.peptides.2015.05.003. [DOI] [PubMed] [Google Scholar]
  • 61.Rhodes CJ. Type 2 diabetes-a matter of beta-cell life and death? Science. 2005;307:380–384. doi: 10.1126/science.1104345. [DOI] [PubMed] [Google Scholar]
  • 62.Taniguchi CM, Ueki K, Kahn R. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Invest. 2005;115:718–727. doi: 10.1172/JCI23187. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 63.Ide T, et al. SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat Cell Biol. 2004;6:351–357. doi: 10.1038/ncb1111. [DOI] [PubMed] [Google Scholar]
  • 64.Anai M, et al. Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes. 1998;47:13–23. doi: 10.2337/diab.47.1.13. [DOI] [PubMed] [Google Scholar]
  • 65.Gould GW, Holman GD. The glucose transporter family: structure, function and tissue-specific expression. Biochem J. 1993;295(Pt 2):329–341. doi: 10.1042/bj2950329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Aravinthan A, et al. Selective insulin resistance in hepatocyte senescence. Exp Cell Res. 2015;331:38–45. doi: 10.1016/j.yexcr.2014.09.025. [DOI] [PubMed] [Google Scholar]
  • 67.Purushotham A, Schug TT, Li X. SIRT1 performs a balancing act on the tight-rope toward longevity. Aging (Albany NY) 2009;1:669–673. doi: 10.18632/aging.100076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Favero G, Franceschetti L, Rodella LF, Rezzani R. Sirtuins, aging, and cardiovascular risks. Age (Dordr) 2015;37:9804. doi: 10.1007/s11357-015-9804-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.de Kreutzenberg SV, et al. Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes. 2010;59:1006–1015. doi: 10.2337/db09-1187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Yzydorczyk C, et al. Neonatal oxygen exposure in rats leads to cardiovascular and renal alterations in adulthood. Hypertension. 2008;52:889–895. doi: 10.1161/HYPERTENSIONAHA.108.116251. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Full-length blots (1.9MB, pdf)

Data Availability Statement

All data generated or analysed during this study are included in this published article.

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES